triazoles has been researched along with 1,3,4-oxadiazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| He, LQ; Jiang, AQ; Liu, ZJ; Luo, Y; Yang, YH; Zhang, S; Zhu, HL | 1 |
| Chen, X; Li, S; Lv, Q; Tu, G; Wang, J; Yan, Y | 1 |
| Qin, L; Zard, SZ | 1 |
| Bantu, R; Gurrala, S; Jain, N; Nagarapu, L; Polepalli, S; Srujana, G; Yadagiri, B | 1 |
| Al-Blewi, FF; Al-Yahyawi, AM; Aouad, MR; Bardaweel, SK; Rezki, N | 1 |
| Bai, CG; Chen, Y; Chu, XQ; Ding, YH; Li, HY; Li, YT; Meng, FF; Pan, CW; Qu, WZ; Wang, JH; Yang, C; Zhang, Q | 1 |
| Joshi, RA; Joshi, RR; Likhite, AP; Nawale, L; Rode, ND; Sarkar, D; Sonawane, AD | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
| Baev, DS; Frolova, TS; Popov, SA; Semenova, MD; Shults, EE; Turks, M; Wang, C | 1 |
| Bansode, MU; Doshi, GM; Somani, RR | 1 |
| Kaneko, D; Koketsu, M; Ninomiya, M; Nishina, A; Ono, Y; Sonawane, AD; Tanaka, K; Yoshikawa, R | 1 |
| Abdel-Aziz, SA; Aboraia, AS; El-Koussi, NA; Gomaa, HAM; Hofny, HA; Mohamed, MFA; Youssif, BGM | 1 |
| A A Abd El-Wahab, H; Abdel-Fattah, HA; E A Hassan, A; Ghanim, AM; Hamoud, MMS; Osman, NA; Rezq, S; Romero, DG | 1 |
13 other study(ies) available for triazoles and 1,3,4-oxadiazole
| Article | Year |
|---|---|
Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
Topics: Antineoplastic Agents; Focal Adhesion Protein-Tyrosine Kinases; HT29 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Oxadiazoles; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2013 |
Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Hep G2 Cells; HT29 Cells; Humans; K562 Cells; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2013 |
Radical-based route to 2-(trifluoromethyl)-1,3,4-oxadiazoles and trifluoromethyl-substituted polycyclic 1,2,4-triazoles and dihydrofurans.
Topics: Alkenes; Cycloaddition Reaction; Furans; Molecular Structure; Oxadiazoles; Triazoles | 2015 |
Synthesis and evaluation of benzosuberone embedded with 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole moieties as new potential anti proliferative agents.
Topics: Antineoplastic Agents; Azoles; Cell Line, Tumor; Cell Proliferation; Coumarins; Humans; Molecular Structure; Oxadiazoles; Thiadiazoles; Triazoles | 2015 |
Synthesis of Novel 2,5-Disubstituted-1,3,4-thiadiazoles Clubbed 1,2,4-Triazole, 1,3,4-Thiadiazole, 1,3,4-Oxadiazole and/or Schiff Base as Potential Antimicrobial and Antiproliferative Agents.
Topics: Anti-Infective Agents; Antineoplastic Agents; Oxadiazoles; Proton Magnetic Resonance Spectroscopy; Schiff Bases; Thiadiazoles; Triazoles | 2015 |
Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Imatinib Mesylate; K562 Cells; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2016 |
Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Topics: Antitubercular Agents; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Thiones; Triazoles; Tuberculosis | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Synthesis of cytotoxic urs-12-ene- and 28-norurs-12-ene- type conjugates with amino- and mercapto-1,3,4-oxadiazoles and mercapto-1,2,4-triazoles.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Oxadiazoles; Stereoisomerism; Triazoles; Triterpenes | 2020 |
Evaluation of Biological Activity of Derivatives of 1,3,4-Thiadiazole, 1,3,4-Oxadiazole and 1,2,4-Triazole.
Topics: Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Edema; Erythrocyte Membrane; Female; Male; Oxadiazoles; Peptide Hydrolases; Protease Inhibitors; Rats; Thiadiazoles; Triazoles | 2021 |
Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxadiazoles; Quinoxalines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2020 |
Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Quinolines; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triazoles | 2021 |
Design and Synthesis of Novel 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives as Cyclooxygenase-2 Inhibitors with Anti-inflammatory and Antioxidant activity in LPS-stimulated RAW264.7 Macrophages.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Interleukin-6; Lipopolysaccharides; Macrophages; Molecular Docking Simulation; Nitric Oxide; Oxadiazoles; Reactive Oxygen Species; Structure-Activity Relationship; Triazoles | 2022 |